ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... BMJ 355, i4919, 2016 | 11825 | 2016 |
Grading quality of evidence and strength of recommendations GWG Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter, A D Oxman G Guyatt, R ... BMJ 328 (19), 1490-4, 2004 | 8875* | 2004 |
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both BJ Shea, BC Reeves, G Wells, M Thuku, C Hamel, J Moran, D Moher, ... BMJ 358, j4008, 2017 | 7723 | 2017 |
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews BJ Shea, C Hamel, GA Wells, LM Bouter, E Kristjansson, J Grimshaw, ... Journal of clinical epidemiology 62 (10), 1013-1020, 2009 | 2039 | 2009 |
Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion DA Henry, PA Carless, AJ Moxey, D O'Connell, BJ Stokes, DA Fergusson, ... Cochrane database of systematic reviews, 2011 | 1861 | 2011 |
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion JL Carson, SJ Stanworth, N Roubinian, DA Fergusson, D Triulzi, C Doree, ... Cochrane database of systematic reviews, 2016 | 1572 | 2016 |
Selling sickness: the pharmaceutical industry and disease mongeringCommentary: Medicalisation of risk factors R Moynihan, I Heath, D Henry Bmj 324 (7342), 886-891, 2002 | 1572 | 2002 |
Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 P McGettigan, D Henry Jama 296 (13), 1633-1644, 2006 | 1534 | 2006 |
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel DN Juurlink, T Gomes, DT Ko, PE Szmitko, PC Austin, JV Tu, DA Henry, ... Cmaj 180 (7), 713-718, 2009 | 1282 | 2009 |
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group D Atkins, M Eccles, S Flottorp, GH Guyatt, D Henry, S Hill, A Liberati, ... BMC health services research 4, 1-7, 2004 | 1280 | 2004 |
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis D Henry, LLY Lim, LAG Rodriguez, SP Gutthann, JL Carson, M Griffin, ... Bmj 312 (7046), 1563-1566, 1996 | 1224 | 1996 |
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post‐menopausal osteoporosis A Avenell, WJ Gillespie, LD Gillespie, D O'Connell Cochrane Database of Systematic Reviews, 2005 | 959 | 2005 |
Preventing overdiagnosis: how to stop harming the healthy R Moynihan, J Doust, D Henry Bmj 344, e3502, 2012 | 875 | 2012 |
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies P McGettigan, D Henry PLoS medicine 8 (9), e1001098, 2011 | 777 | 2011 |
Cell salvage for minimising perioperative allogeneic blood transfusion PA Carless, DA Henry, AJ Moxey, D O'Connell, T Brown, DA Fergusson Cochrane database of systematic reviews, 2010 | 776 | 2010 |
Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem J Page, D Henry Archives of internal medicine 160 (6), 777-784, 2000 | 751 | 2000 |
Coverage by the news media of the benefits and risks of medications R Moynihan, L Bero, D Ross-Degnan, D Henry, K Lee, J Watkins, C Mah, ... New England journal of medicine 342 (22), 1645-1650, 2000 | 719 | 2000 |
Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries P McGettigan, D Henry PLoS medicine 10 (2), e1001388, 2013 | 542 | 2013 |
Tricyclic drugs for depression in children and adolescents P Hazell, M Mirzaie Cochrane Database of Systematic Reviews, 2013 | 501 | 2013 |
The fight against disease mongering: generating knowledge for action R Moynihan, D Henry PLoS medicine 3 (4), e191, 2006 | 441 | 2006 |